Duran Felipe 4
4 · iBio, Inc. · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
iBio (IBIO) CFO Duran Felipe Buys 24,835 Shares
What Happened Duran Felipe, Chief Financial Officer of iBio, Inc. (IBIO), made an open-market purchase of 24,835 shares on March 19, 2026. The shares were acquired at prices in a narrow range ($2.01–$2.02) with a weighted average price of $2.0186, for a total reported outlay of approximately $50,132. This transaction is coded as a purchase (P), which is generally viewed as a direct acquisition of company stock.
Key Details
- Transaction date: 2026-03-19 (filed on Form 4: 2026-03-23; filing appears timely)
- Shares purchased: 24,835
- Price: range $2.01–$2.02; weighted average $2.0186 (rounded $2.02)
- Total value: ~$50,132
- Transaction type/code: Open-market purchase (P)
- Shares owned after transaction: Not specified in the provided Form 4 excerpt
- Footnote: Reporting person states purchases occurred in multiple trades within the $2.01–$2.02 range and will provide a per-trade breakdown upon request to the company, shareholders, or SEC staff
Context This was a straight purchase of common stock (not an option exercise, gift, or tax withholding). Purchases by executives can be interpreted by some investors as a positive signal (management acquiring company stock), but filings are factual records and do not state motivation.
Insider Transaction Report
- Purchase
Common Stock
[F1]2026-03-19$2.02/sh+24,835$50,132→ 35,974 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock purchased by the Reporting Person in multiple transactions at prices ranging from $2.01 through $2.02, inclusive, having a weighted average price as shown in column 4 of $2.0186. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range.